0001213900-22-039458.txt : 20220714 0001213900-22-039458.hdr.sgml : 20220714 20220714192609 ACCESSION NUMBER: 0001213900-22-039458 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220627 FILED AS OF DATE: 20220714 DATE AS OF CHANGE: 20220714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Knudsen Jens Erik CENTRAL INDEX KEY: 0001888257 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41160 FILM NUMBER: 221084017 MAIL ADDRESS: STREET 1: 210 BROADWAY, STE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allarity Therapeutics, Inc. CENTRAL INDEX KEY: 0001860657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 BROADWAY STREET 2: SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 401-426-4664 MAIL ADDRESS: STREET 1: 210 BROADWAY STREET 2: SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 ownership.xml X0306 4 2022-06-27 1 0001860657 Allarity Therapeutics, Inc. ALLR 0001888257 Knudsen Jens Erik 1260 APPALACHIAN ROAD MAPLE GLEN PA 19002 0 1 0 0 Former Chief Financial Officer This "Exit" Form 4 is being voluntarily filed to report solely that the Reporting Person is no longer serving in the role as the Company's Chief Financial Officer effective as of June 27, 2022. /s/ Jens Erik Knudsen 2022-07-14